$HUTCHMED(00013)$ Last month,

$HUTCHMED(00013)$ Last month, the company announced the sale of a 45% stake in Shanghai and Huang Pharmaceutical for 4.478 billion yuan. This move is clearly a strategic shift, with the company opting to divest profitable assets and focus its resources on innovative drugs.

The shift indicates the company’s belief in the higher ROI of investing in innovation. Particularly the new generation of antibody-drug conjugates (ADC) platform, which holds immense potential.

If things go smoothly, the first candidate drug could enter clinical trials by the second half of 2025, opening up new growth opportunities for the company.

Winning Trades

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":405602484814240,"tweetId":"405602484814240","gmtCreate":1740051559732,"gmtModify":1740057608711,"author":{"id":9000000000000656,"idStr":"9000000000000656","authorId":9000000000000656,"authorIdStr":"9000000000000656","name":"CecilFranklin","avatar":"https://static.tigerbbs.com/9fa4731ac634473d4f9e536afcd38ccc","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":8,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/7aa961fa27b9349fb00db56bdf91838c","width":"696","height":"1122"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/7aa961fa27b9349fb00db56bdf91838c","width":"696","height":"1122"}],"html":"<html><head></head><body> <a data-mention-id=\"00013\" class=\"teditor-mention\" data-mention-name=\"HUTCHMED\" href=\"https://ttm.financial/S/00013\">$HUTCHMED(00013)$</a> Last month, the company announced the sale of a 45% stake in Shanghai and Huang Pharmaceutical for 4.478 billion yuan. This move is clearly a strategic shift, with the company opting to divest profitable assets and focus its resources on innovative drugs. The shift indicates the company’s belief in the higher ROI of investing in innovation. Particularly the new generation of antibody-drug conjugates (ADC) platform, which holds immense potential. If things go smoothly, the first candidate drug could enter clinical trials by the second half of 2025, opening up new growth opportunities for the company.<img src=\"https://community-static.tradeup.com/news/7aa961fa27b9349fb00db56bdf91838c\" tg-width=\"696\" tg-height=\"1122\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"00013\" class=\"teditor-mention\" data-mention-name=\"HUTCHMED\" href=\"https://ttm.financial/S/00013\">$HUTCHMED(00013)$</a> Last month, the company announced the sale of a 45% stake in Shanghai and Huang Pharmaceutical for 4.478 billion yuan. This move is clearly a strategic shift, with the company opting to divest profitable assets and focus its resources on innovative drugs. The shift indicates the company’s belief in the higher ROI of investing in innovation. Particularly the new generation of antibody-drug conjugates (ADC) platform, which holds immense potential. If things go smoothly, the first candidate drug could enter clinical trials by the second half of 2025, opening up new growth opportunities for the company.<img src=\"https://community-static.tradeup.com/news/7aa961fa27b9349fb00db56bdf91838c\" tg-width=\"696\" tg-height=\"1122\"></body></html>","text":"$HUTCHMED(00013)$ Last month, the company announced the sale of a 45% stake in Shanghai and Huang Pharmaceutical for 4.478 billion yuan. This move is clearly a strategic shift, with the company opting to divest profitable assets and focus its resources on innovative drugs. The shift indicates the company’s belief in the higher ROI of investing in innovation. Particularly the new generation of antibody-drug conjugates (ADC) platform, which holds immense potential. If things go smoothly, the first candidate drug could enter clinical trials by the second half of 2025, opening up new growth opportunities for the company.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/405602484814240","repostId":0,"isVote":1,"tweetType":1,"viewCount":616,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["00013","HCM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":529,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/405602484814240"}